Takeda

head to head against clash football helmets fight combat

Takeda’s TYK2 inhibitor beats BMS’ Sotyktu in psoriasis showdown

Takeda has won the battle of the TYK2 inhibitors, toppling Bristol Myers Squibb’s Sotyktu to strengthen its hand ahead of an anticipated plaque psoriasis launch next year.

Nick Paul Taylor Jun 11, 2026 7:00am

An arrow incrementally going up stairs before pointing straight up Blue background

Innovent, fresh from $1.2B deal, posts key win for CLDN18.2 ADC

Jun 4, 2026 7:47am

Fierce Pharma

At ASCO, China biotech industry cements its coming of age

Jun 3, 2026 8:50am

ASCO: Takeda touts ‘tremendous potential’ of Innovent bispecific

Jun 2, 2026 4:30am

Takeda 0 for 4 against nausea and vomiting after axing asset

May 13, 2026 5:08am

Takeda drug improves convenience for PID patients in pivotal trial

May 4, 2026 10:48am